AHCO Earnings Date: Nov 3, 2026 (Estimated) — AdaptHealth Corp.
NASDAQ · Healthcare · Medical Devices
Updated
When is AHCO's next earnings date?
AdaptHealth Corp. (AHCO) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.05 on revenue of $725.9M.
How did AHCO do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), AdaptHealth Corp. posted EPS of $0.08 versus the $0.17 estimate, a miss of 35.0%. Revenue was $740.3M against a $846.8M estimate. The stock's 1-day post-earnings move was -38.0%.
How much does AHCO stock move after earnings?
AHCO beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 18.2% (up or down) in the day after earnings.
About AdaptHealth Corp.
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 0.17 | 0.08 | -35.00% | $740.3M | ❌ Miss | -38.04% | -51.80% | -49.12% |
| 2026-05-05 | Q1 2026 | -0.01 | -0.05 | -400.00% | $819.8M | ❌ Miss | -9.89% | -13.80% | -25.46% |
| 2026-02-24 | Q4 2025 | 0.32 | 0.19 | -40.62% | $846.3M | ❌ Miss | -13.95% | -6.32% | +11.56% |
| 2025-11-04 | Q3 2025 | 0.23 | 0.16 | -30.43% | $820.3M | ❌ Miss | +17.38% | +3.41% | +2.75% |
| 2025-08-05 | Q2 2025 | 0.14 | 0.10 | -28.57% | $800.4M | ❌ Miss | +10.98% | +2.41% | -0.22% |
| 2025-02-25 | Q4 2024 | 0.28 | 0.34 | +21.43% | $856.6M | ✅ Beat | +24.44% | +28.66% | +20.35% |
| 2024-11-05 | Q3 2024 | 0.17 | 0.17 | +0.00% | $805.9M | ➖ Inline | -9.56% | +2.96% | -4.53% |
| 2024-08-06 | Q2 2024 | 0.16 | 0.17 | +6.25% | $806.0M | ✅ Beat | -21.06% | -14.22% | +2.37% |
Showing last 8 quarters.